ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
CalciMedica Inc

CalciMedica Inc (CALC)

4.14
0.23
(5.88%)
Closed September 19 4:00PM
4.14
0.00
(0.00%)
After Hours: 7:53PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
4.14
Bid
3.90
Ask
4.18
Volume
9,211
3.94 Day's Range 4.15
1.75 52 Week Range 8.38
Market Cap
Previous Close
3.91
Open
3.94
Last Trade
13
@
4.14
Last Trade Time
Financial Volume
$ 37,555
VWAP
4.0772
Average Volume (3m)
56,362
Shares Outstanding
10,750,156
Dividend Yield
-
PE Ratio
-1.27
Earnings Per Share (EPS)
-3.2
Revenue
-
Net Profit
-34.36M

About CalciMedica Inc

CalciMedica, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for life-threatening inflammatory diseases with high unmet needs. Its technology targets the inhibition of Calcium Release-Activated Calcium (CRAC) channels designed to modulate the immune... CalciMedica, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for life-threatening inflammatory diseases with high unmet needs. Its technology targets the inhibition of Calcium Release-Activated Calcium (CRAC) channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases. CRAC channels serve to replenish calcium levels in the endoplasmic reticulum (ER) and provide calcium for cellular signaling events. Its lead product candidate, Auxora, is an intravenous-formulated, small molecule CRAC channel inhibitor. Auxora has the capability to modulate the immune response and protect against tissue cell injury, addressing inflammatory diseases, such as acute pancreatitis (AP), asparaginase-associated acute pancreatitis (AAP), acute kidney injury (AKI), and acute hypoxemic respiratory failure. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
CalciMedica Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CALC. The last closing price for CalciMedica was $3.91. Over the last year, CalciMedica shares have traded in a share price range of $ 1.75 to $ 8.38.

CalciMedica currently has 10,750,156 shares outstanding. The market capitalization of CalciMedica is $42.03 million. CalciMedica has a price to earnings ratio (PE ratio) of -1.27.

CALC Latest News

CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference

CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference PR Newswire LA JOLLA, Calif., Sept. 3, 2024 LA JOLLA, Calif., Sept. 3, 2024 /PRNewswire/ -- CalciMedica Inc...

CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates PR Newswire LA JOLLA, Calif., Aug. 12, 2024 Positive topline data announced from CARPO...

CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora™ in Severe Acute Kidney Injury (AKI)

CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora™ in Severe Acute Kidney Injury (AKI) PR Newswire LA JOLLA, Calif., July 9, 2024 Development of Auxora in AKI is...

CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences

CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences PR Newswire LA JOLLA, Calif., July 8, 2024 LA JOLLA, Calif., July 8, 2024 /PRNewswire/ -- CalciMedica Inc...

CalciMedica Set to Join Russell Microcap® Index

CalciMedica Set to Join Russell Microcap® Index PR Newswire LA JOLLA, Calif., July 1, 2024 LA JOLLA, Calif., July 1, 2024 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company...

CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) PR Newswire LA JOLLA, Calif., June 27, 2024 Primary objective of the trial met with...

CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) PR Newswire LA JOLLA, Calif., June 26, 2024 Conference call and webcast...

CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates

CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates PR Newswire LA JOLLA, Calif., May 13, 2024 Last patient enrolled in CARPO, Phase 2b trial of...

CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024

CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024 PR Newswire LA JOLLA, Calif., May 7, 2024 Collaborators from Cedars-Sinai to present human proteomics data supporting...

CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis

CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis PR Newswire LA JOLLA, Calif., April 24, 2024 Full target enrollment of 216 patients...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.095-2.243211334124.2354.393.77210663.99857313CS
40.246.153846153853.95.972.91655674.58360261CS
120.276.976744186053.875.972.91563624.15547018CS
260.4813.11475409843.666.2652.91357524.39208054CS
521.0533.98058252433.098.381.75276974.18936641CS
156-12.24-74.725274725316.3816.381.17111984.2173235CS
260-12.24-74.725274725316.3816.381.1784694.2173235CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GSIWGarden Stage Ltd
$ 8.17
(259.91%)
70.64M
ZEOZeo Energy Corporation
$ 2.5995
(128.03%)
58.94M
TBIOTelesis Bio Inc
$ 2.9201
(114.71%)
45.91M
NCINeo Concept International Group Holdings Ltd
$ 0.84
(71.43%)
12.68M
VEROVenus Concept Inc
$ 0.8475
(68.66%)
19.72M
HAOHaoxi Health Technology Ltd
$ 0.83
(-72.33%)
7.93M
PGNYProgyny Inc
$ 16.465
(-32.63%)
17.44M
NUZENuZee Inc
$ 0.6998
(-32.06%)
14.04M
RGFReal Good Food Company Inc
$ 0.308
(-28.37%)
360.79k
ALGSAligos Therapeutics Inc
$ 10.18
(-28.11%)
839.92k
NVDANVIDIA Corporation
$ 117.87
(3.97%)
293.54M
SQQQProShares UltraPro Short QQQ
$ 7.76
(-7.62%)
222.56M
HOLOMicroCloud Hologram Inc
$ 0.2328
(15.08%)
120.19M
MAXNMaxeon Solar Technologies Ltd
$ 0.1034
(13.75%)
105.03M
TSLATesla Inc
$ 243.92
(7.36%)
102.7M

Your Recent History

Delayed Upgrade Clock